Thus, our results indicated that loss of Smad4 in murine pancreatic cancer cells promoted tumor cell growth in vitro but paradoxically inhibited tumor growth in vivo, likely by engaging T cell‐mediated antitumor immunity. The gene discussed is SMAD4; the disease is familial pancreatic carcinoma.